JP2001504461A5 - - Google Patents

Download PDF

Info

Publication number
JP2001504461A5
JP2001504461A5 JP1998522063A JP52206398A JP2001504461A5 JP 2001504461 A5 JP2001504461 A5 JP 2001504461A5 JP 1998522063 A JP1998522063 A JP 1998522063A JP 52206398 A JP52206398 A JP 52206398A JP 2001504461 A5 JP2001504461 A5 JP 2001504461A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998522063A
Other languages
Japanese (ja)
Other versions
JP2001504461A (en
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK1997/000524 external-priority patent/WO1998020872A1/en
Publication of JP2001504461A publication Critical patent/JP2001504461A/en
Publication of JP2001504461A5 publication Critical patent/JP2001504461A5/ja
Ceased legal-status Critical Current

Links

Description

Figure 2001504461
Figure 2001504461
Figure 2001504461
Figure 2001504461
Figure 2001504461
Figure 2001504461
Figure 2001504461
Figure 2001504461
Figure 2001504461
Figure 2001504461
Figure 2001504461
Figure 2001504461

JP52206398A 1996-11-14 1997-11-14 Topical preparation for treating mucosal infections containing fatty acids or fatty alcohols or their monoglyceride derivatives as therapeutic active ingredients Ceased JP2001504461A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IS4386 1996-11-14
IS4386 1996-11-14
PCT/DK1997/000524 WO1998020872A1 (en) 1996-11-14 1997-11-14 Topical formulations containing as a therapeutic active agent fatty acids or fatty alcohols or monoglyceride derivatives thereof for treating of mucosa infections

Publications (2)

Publication Number Publication Date
JP2001504461A JP2001504461A (en) 2001-04-03
JP2001504461A5 true JP2001504461A5 (en) 2005-07-14

Family

ID=36699955

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52206398A Ceased JP2001504461A (en) 1996-11-14 1997-11-14 Topical preparation for treating mucosal infections containing fatty acids or fatty alcohols or their monoglyceride derivatives as therapeutic active ingredients

Country Status (10)

Country Link
US (1) US6596763B1 (en)
EP (1) EP0941087B1 (en)
JP (1) JP2001504461A (en)
AP (1) AP1209A (en)
AT (1) ATE442844T1 (en)
AU (1) AU729546B2 (en)
CA (1) CA2271843A1 (en)
DE (1) DE69739583D1 (en)
IS (1) IS5051A (en)
WO (1) WO1998020872A1 (en)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19648545B4 (en) 1996-11-25 2009-05-07 Ceramtec Ag Monolithic multilayer actuator with external electrodes
CA2294345C (en) * 1997-06-20 2006-11-21 Sabine Eggers A skin-protective composition
US6096332A (en) * 1998-06-30 2000-08-01 Mcneil-Ppc, Inc. Adding pharmaceutically active compounds to substrates
IL137559A (en) * 2000-07-27 2006-12-31 Amnon Sintov Transdermal drug delivery system
CA2431205C (en) * 2000-12-05 2005-08-23 Alexander Macgregor Hydrostatic delivery system for controlled delivery of agent
BRPI0214256B8 (en) * 2001-11-19 2021-05-25 Medigene Ag medicine
DE10156794B4 (en) * 2001-11-19 2006-05-18 Medigene Ag Medicines for the treatment of warts
US20050032896A1 (en) * 2002-06-21 2005-02-10 Liisa Neumann Use of synthetic retinoic acid in form of 13-cis vitamin A for treatment of autism
US20050095281A1 (en) * 2003-03-14 2005-05-05 Optime Therapeutics, Inc. Liposomal formulations and methods of use
ES2237298B1 (en) 2003-07-16 2006-11-01 Italfarmaco, S.A. SEMISOLID MUCOADHESIVE FORMULATIONS.
GB0317999D0 (en) * 2003-07-31 2003-09-03 Univ Liege Improvements in or relating to drug delivery systems
AU2004270266B2 (en) * 2003-09-09 2011-02-10 3M Innovative Properties Company Concentrated antimicrobial compositions and methods
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
BRPI0415215B8 (en) 2003-10-09 2021-05-25 Medigene Ag use of polyphenol in drug preparation
US20050079235A1 (en) * 2003-10-09 2005-04-14 Eggert Stockfleth Use of a polyphenol for the treatment of actinic keratosis
EP1691743A4 (en) * 2003-11-11 2010-08-25 Univ Minnesota Regulation of cell membrane-mediated effects
US8796332B2 (en) 2004-08-03 2014-08-05 Regents Of The University Of Minnesota Compositions and methods for controlling infections
CA2578404A1 (en) * 2004-08-23 2006-03-02 Auckland Uniservices Limited Gastric therapies and compositions therefor
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
EP1833298B1 (en) * 2004-12-17 2013-05-08 Halldor Thormar Stable concentrated anti-bacterial emulsions of monocaprin in water
CA2599653A1 (en) 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of reducing microbial contamination
US8476319B2 (en) 2005-03-10 2013-07-02 3M Innovative Properties Company Methods of treating ear infections
CA2598985A1 (en) * 2005-03-10 2006-09-21 3M Innovative Properties Company Antimicrobial pet wipes and methods
US20060229364A1 (en) * 2005-03-10 2006-10-12 3M Innovative Properties Company Antiviral compositions and methods of use
MX2007010908A (en) 2005-03-10 2007-12-05 3M Innovative Properties Co Antimicrobial compositions comprising esters of hydroxycarboxylic acids.
US20080075793A1 (en) * 2006-09-21 2008-03-27 Dunshee Wayne K Antiviral compositions and methods of use
EP2060192B9 (en) * 2007-10-17 2016-05-04 Rudolf Wild GmbH & Co. KG Composition comprising lemon balm extracts
JP2009155257A (en) * 2007-12-26 2009-07-16 Taiyo Corp Antibacterial agent and oral composition, food and drink containing the same
ES2344673B1 (en) 2008-08-07 2011-05-03 Italfarmaco, S.A. USE OF ESTRIOL IN THE PREPARATION OF A PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF VAGINAL ATROPHY IN WOMEN WITH RISK OF POTOLOGIATUMORAL.
ES2344675B1 (en) 2008-12-19 2011-04-28 Italfarmaco, S.A. USE OF ESTRIOL IN THE PREPARATION OF A PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF VAGINAL ATROPHY IN WOMEN WITH RISK OF VARIUM VARCOLOGY.
DE102009008094A1 (en) 2009-02-09 2010-08-19 Barnikol-Keuten, Doris, Dr. In situ adhesive gel-forming preparations, in particular for topical application to moisturized skin / mucosa
PL3023009T3 (en) 2009-08-06 2017-07-31 Anitox Corporation Water and feed preservative
WO2011057133A1 (en) 2009-11-09 2011-05-12 Spotlight Technology Partners Llc Fragmented hydrogels
JP5864429B2 (en) 2009-11-09 2016-02-17 スポットライト テクノロジー パートナーズ エルエルシーSpotlight Technology Partners Llc Crosslinked hydrogel composition, method of forming hydrogel composition, and kit
WO2012035751A1 (en) * 2010-09-14 2012-03-22 日油株式会社 Antibacterial cleaning composition
JP5749915B2 (en) * 2010-11-02 2015-07-15 花王株式会社 Autoinducer-2 inhibitor
WO2012078155A1 (en) * 2010-12-09 2012-06-14 The Research Foundation Of State University Of New York Nitric oxide and its biomedical significance
EP2696677B1 (en) 2011-04-13 2021-08-11 BioSafe Technologies, Inc. Insecticide, insect repellant and anti-irritation composition
CA2848777A1 (en) 2011-10-20 2013-04-25 Anitox Corporation Antimicrobial formulations with pelargonic acid
EP2785205B1 (en) 2011-11-30 2020-12-30 Anitox Corporation Antimicrobial mixture of aldehydes, organic acids and organic acid esters
HUE055946T2 (en) * 2016-06-20 2022-01-28 Capretto Ehf Synergistic effects, augmenting antimicrobial effects of lipids
US20200069630A1 (en) * 2016-07-11 2020-03-05 Hennipen Life Sciences, Llc Compositions for sexually transmitted diseases
JP6754030B2 (en) * 2017-04-20 2020-09-09 マイクロアルジェコーポレーション株式会社 Method for Producing Monoacylglycerol, Antibacterial Agent, and Monoacylglycerol
US11246872B2 (en) 2019-06-14 2022-02-15 Propella Therapeutics, Inc. Topical acyclovir formulations and uses thereof
US11572342B2 (en) 2020-09-18 2023-02-07 Niche Biopharmaceuticals LLC Antimicrobial and antiviral sulfur containing glycerol monoester derivatives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406884A (en) * 1981-06-23 1983-09-27 The Procter & Gamble Company Topical antimicrobial composition
US4520132A (en) * 1982-09-27 1985-05-28 Pennwalt Corporation Use of undecylenic acid to treat herpes labialis
MX168518B (en) * 1982-09-30 1993-05-27 Union Carbide Corp MODEL COMPOSITIONS CONTAINING CURABLE EPOXY RESIN
US5208257A (en) 1986-04-21 1993-05-04 Kabara Jon J Topical antimicrobial pharmaceutical compositions and methods
US5434182A (en) * 1987-12-31 1995-07-18 Isaacs; Charles E. Antibacterial fatty acid compositions
US5342625A (en) 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
NZ250714A (en) * 1990-10-30 1996-05-28 Mcneil Ppc Inc Liquid composition comprising esters of higher fatty acids for use as a vaginal douche and to prevent toxic shock toxin production
IL104283A (en) * 1992-12-30 1996-12-05 Agis Ind 1983 Ltd Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate
IL110380A0 (en) 1994-07-20 1994-10-21 Agis Ind 1983 Ltd Antiviral topical pharmaceutical compositions
IL163865A0 (en) 1996-09-17 2005-12-18 Avanir Pharmaceuticals Compositions comprising a non-ionicsurfactant and n-docosanol

Similar Documents

Publication Publication Date Title
JP2000502280A5 (en)
JP2000501771A5 (en)
JP2001507965A5 (en)
JP2000501018A5 (en)
JP2000500076A5 (en)
JP2000501324A5 (en)
JP2000500026A5 (en)
JP2000501338A5 (en)
JP2000502472A5 (en)
JP2000501825A5 (en)
JP2000500874A5 (en)
JP2000502485A5 (en)
JP2000502425A5 (en)
JP2000501774A5 (en)
JP2001506118A5 (en)
JP2000502570A5 (en)
JP2000500912A5 (en)
JP2000502568A5 (en)
JP2000501876A5 (en)
JP2000501744A5 (en)
JP2000502316A5 (en)
JP2000500857A5 (en)
JP2000502714A5 (en)
JP2000501229A5 (en)
JP2000500318A5 (en)